SPECTRO Analytical Instruments acquired by AMETEK
SPECTRO Analytical Instruments announced that it has been acquired by AMETEK, Inc., a leading global manufacturer of electronic instruments and electric motors. SPECTRO was acquired from an investor group led by German Equity Partners BV for approximately EUR80 million ($98 million). With its headquarters in Kleve, Germany, SPECTRO has annual sales of approximately EUR85 million ($104 million).
SPECTRO joins AMETEK as part of its Electronic Instruments Group (EIG) - a recognized leader in advanced monitoring, testing, calibrating and display instruments. AMETEK EIG sells its instruments to the process, aerospace, power and industrial markets worldwide and had 2004 sales of approximately $667 million.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Wave of the future - Terahertz chips a new way of seeing through matter
Analysis true biological signatures without altering, stressing, or damaging cells - LevitasBio Completes Series C Financing of $35 million
Out of REACH - New legislation threatens medicines
Molecules pass through nanotubes at size-dependent speeds
New method to performance-enhancing drugs
Optical nanoantennas set the stage for a NEMS lab-on-a-chip revolution
Verder Group acquires specialist for particle characterization
Study of COPD patients has created a 'looking glass' into genome of pathogen